Page last updated: 2024-08-24

venlafaxine hydrochloride and Tobacco Use Disorder

venlafaxine hydrochloride has been researched along with Tobacco Use Disorder in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cinciripini, L; Cinciripini, P; De Moor, C; Minna, J; Tomlinson, G; Tsoh, J; Wetter, D1
Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW1
Chen, MC; Lane, HY; Lin, CH; Lin, CY; Lin, KS1

Trials

2 trial(s) available for venlafaxine hydrochloride and Tobacco Use Disorder

ArticleYear
The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2004, Volume: 6, Issue:2

    Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Double-Blind Method; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride

2004
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
    Experimental and clinical psychopharmacology, 2005, Volume: 13, Issue:4

    Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride

2005

Other Studies

1 other study(ies) available for venlafaxine hydrochloride and Tobacco Use Disorder

ArticleYear
Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
    The Journal of clinical psychiatry, 2008, Volume: 69, Issue:1

    Topics: Adult; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Interview, Psychological; Male; Mood Disorders; Patient Readmission; Prevalence; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Venlafaxine Hydrochloride

2008